Dosage Safety

The start-low-go-slow principle is fundamental to safe peptide dosing. Begin at the lowest recommended dose and increase gradually over days or weeks, allowing time to assess individual response and tolerability at each level.

Titration serves multiple purposes: it identifies your minimum effective dose (reducing unnecessary exposure), allows early detection of side effects before they become severe, and helps avoid receptor desensitization that can occur with high initial doses.

A typical titration schedule might involve starting at 25-50% of the target dose for the first week, increasing to 75% in the second week, and reaching the full dose by week three — but specific protocols vary by compound.

Peptide dosing uses several units that are critical to distinguish: milligrams (mg) represent one thousandth of a gram; micrograms (mcg or μg) represent one millionth of a gram — there are 1,000 mcg in 1 mg. Confusing these is a 1,000-fold dosing error.

International Units (IU) are a measure of biological activity, not weight. The conversion between IU and mg/mcg varies by compound and cannot be generalized. For example, 1 IU of HGH equals approximately 333 mcg, but this ratio does not apply to other peptides.

Syringe units (on an insulin syringe) measure volume, not dose. A standard U-100 insulin syringe has 100 units per 1 mL. The actual dose depends on the concentration of your reconstituted solution.

Always calculate your dose based on the concentration after reconstitution: Dose (in syringe units) = (Desired dose in mcg ÷ Concentration in mcg per mL) × 100.

Use insulin syringes for precise measurement of small volumes. Choose a syringe size close to your intended injection volume — a 0.3 mL syringe has finer graduation marks than a 1 mL syringe, providing better accuracy for small doses.

When drawing from a vial, hold the syringe at eye level to check the volume. The bottom of the meniscus (the curved surface of the liquid) should align with the desired graduation mark.

After reconstitution, calculate and record the concentration (mcg per unit or mcg per 0.1 mL) and keep this reference accessible. Recalculating from memory introduces error risk.

Double-check your math before every injection, especially when using a new vial or concentration. A simple mislabeled vial or forgotten decimal point can result in a 10x dosing error.

Confusing mg and mcg: This is the most dangerous dosing error. Always verify the unit on the product label and ensure your calculation matches. A 250 mcg dose is not the same as a 250 mg dose.

Forgetting to account for reconstitution volume: Adding 2 mL of water to a 5 mg vial produces a different concentration than adding 1 mL. The peptide amount stays the same — the concentration changes.

Using the wrong syringe type: Standard syringes and insulin syringes have different unit scales. Never use a standard mL syringe reading as insulin units or vice versa.

Not accounting for dead space: Some syringes retain a small amount of solution in the hub (dead space). Low dead-space syringes minimize waste, which matters when working with expensive compounds.

Skipping titration: Jumping straight to a full dose increases side effect risk, can trigger receptor desensitization, and makes it impossible to identify your minimum effective dose.

Reduce dosage or discontinue use if side effects become intolerable, worsen over time instead of resolving, or interfere with daily functioning.

Specific signals to reduce dose: persistent nausea or GI distress, significant water retention, headaches that don't resolve within the first few days, injection site reactions that worsen with each dose.

Discontinue immediately and consult a medical professional if you experience: signs of allergic reaction (hives, swelling, breathing difficulty), severe abdominal pain (possible pancreatitis with GLP-1 agonists), vision changes, heart palpitations or chest pain, signs of hypoglycemia (shakiness, sweating, confusion).